May 2026
📣 VC round data is live. Check it out!
Largest Medical Devices Public Companies in Switzerland
Benchmark revenue and EBITDA valuation multiples for public comps like
Roche, Alcon, Sonova, Ypsomed and Medacta Group.
 | Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales. | $52 | +27% | $330B | $353B | - | - | ||
| Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world. | $66 | -25% | $32B | $36B | 3.4x | 13.3x | ||
| Sonova is one of the world's largest manufacturers and distributors of hearing aids. The company is based in Switzerland and distributes its products in more than 100 countries through its internal sales team and independent retailers. It also sells cochlear implants and audio technologies. | $261 | -13% | $16B | $17B | 3.6x | 13.4x | ||
| Ypsomed Holding AG is a Swiss company that develops and manufactures injection and infusion systems that allow patients to self-administer medication. Specifically, the company focuses on ensuring the ease of diabetes and insulin injection. The company offers various products such as pen needles with a click-on function. The company operates under two reportable segments: Ypsomed Delivery Systems and Ypsomed Diabetes Care. | $430 | -20% | $6B | $6B | 6.4x | 14.3x | ||
| Medacta Group SA is involved in developing, manufacturing and distributing orthopedic and neurosurgical medical devices. The company offers solutions for Hip, Knee, Shoulder and Spine. The majority of the company's revenue is generated from Europe, Middle East, and Africa (EMEA) and the rest from other regions. | $176 | +3% | $4B | $4B | 4.7x | 16.5x | ||
| Tecan Group AG sells automated laboratory instruments and solutions for the diagnostics and life sciences research markets. The firm operates in two segments; The Life Sciences Business (end-customer business) segment supplies end users with automated workflow solutions directly. These solutions include laboratory instruments, software packages, application know-how, services, consumables, and spare parts, The partnering Business (OEM business) segment develops and manufactures OEM instruments and components that are distributed by partner companies under their names. A majority proportion of Tecan's revenue is generated in the Americas and Europe. | $199 | -3% | $3B | $2B | 2.1x | 14.0x | ||
| SKAN Group AG is a market and technological company for isolators, cleanroom devices, and decontamination processes for the aseptic production of biopharmaceutical substances. Its core competency is the design and development of process isolators for the aseptic filling of biopharmaceutical products. The company offers its customers process support, services, and consumables. Its products include biological indicators, isolators, Laboratory/cleanroom equipment, laminar flow, safety workbenches, and transfer systems. The Firm has three operating segments: Equipment & solutions, Services & Consumables, and Other. The company generates the majority of its revenue from the Equipment & solutions segment. Geographically, the company derives revenue from Asia, Europe, Americas, and Other regions. | $63 | -31% | $1B | $1B | 3.4x | 29.9x | ||
| Medartis Holding AG is a medical device company. The company's product profile is divided into APTUS products, StealthFix Products, and MODUS products. APTUS includes products for the Hand, Wrist, Elbow, Shoulder, and Foot. MODUS comprises products for the mandible. Geographically, it derives the majority of its revenue from EMEA and also has a presence in APAC, LATAM, and USA. | $95 | -7% | $1B | $1B | 3.9x | 23.0x | ||
| Kuros Biosciences Ltd is a Swiss-based biopharmaceutical company focused on the development of inventive products for tissue repair and bone regeneration. It operates through the following segments: Medical devices, Pharmaceuticals and Legacy portfolio. The Medical devices segment includes products such as MagnetOs and Attrax. The Pharmaceuticals segment includes products such as Fibrin-PTH, a drug-biologic combination that promotes targeted and controlled bone formation through the induction of osteoprogenitor cell differentiation, enhancement, of osteoblast proliferation and increasing the lifespan of bone-forming cells. The Legacy portfolio segment includes all other products that do not belong to the group's core business strategies. | $25 | -29% | $973M | $950M | 5.1x | 59.4x | ||
| Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. | $15 | -99% | $882M | $601M | 391.2x | (5.6x) | ||
| Medmix AG delivers technologies in high-precision delivery devices and fluid mixing for applications. It is into two business areas Healthcare and Consumer & Industrial. The Healthcare business area is divided into the Dental, Drug Delivery, and Surgery segments. The Consumer & Industrial business area operates through the Industry and Beauty segments. The majority of its revenue is from the Consumer & Industrial segment. In the Industry segment, dispensers, cartridges, and mixers are used in the construction, transportation (automotive, railways, and aerospace), electronics assembly, infrastructure, and DIY industries. Geographically, it operates in Europe the Middle East and Africa, the Americas, and Asia-Pacific. | $11 | -26% | $462M | $769M | 1.3x | 6.8x | ||
| IVF hartmann Holding AG engages in production and supply of medical, pharmaceutical and hygiene products in Switzerland, it offers products such as surgical disposable, disposable dental, first aid, therapeutic plaster, cotton wool, wound care among others. The company operates in four segment wound care, incontinence management, infection management and Other group activities. | $161 | -10% | $382M | $241M | 1.2x | 7.2x | ||
| Coltene Holding AG is a Switzerland based company engaged in developing, manufacturing, and selling a range of disposables and tools for dentists and dental laboratories. The company divides its comprehensive product range into categories such as Infection Control, Dental Preservation, and Efficient Treatment categories. It offers products like aspirator tips, high-performance rotary instruments, dental dams and root canal instruments among others. The firm has its geographic presence in EMEA, North America, Latin America, and Asia/Oceania regions. | $63 | -27% | $377M | $411M | 1.3x | 11.4x | ||
| Ascom Holding AG is a solutions provider focused on healthcare ICT and mobile workflow solutions. The company consists of a business unit, the purpose of which is to use its product and solutions portfolio and software architecture capabilities to devise integration and mobilization solutions that provide digitalized, complete, and efficient workflows for healthcare as well as for industry, security, and retail sectors. The company has three segments OEM, Enterprise, and Healthcare. It derives a majority of its revenue from the healthcare segment. | $8 | +74% | $273M | $252M | 0.7x | 5.7x | ||
| Median | $65 | -17% | $1B | $1B | 3.4x | 13.4x |
Financial data powered by FactSet and Morningstar. Valuation multiples as of current fiscal year. For more data, start your free trial here.
Recent Insights
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.